Back to Search
Start Over
Establishment and validation of a gasdermin signature to evaluate the immune status and direct risk‐group classification in luminal‐B breast cancer
- Source :
- Clinical and Translational Medicine, Vol 11, Iss 11, Pp n/a-n/a (2021), Clinical and Translational Medicine
- Publication Year :
- 2021
- Publisher :
- Wiley, 2021.
- Subjects :
- BRCA2 Protein
Pore Forming Cytotoxic Proteins
Oncology
Immune status
medicine.medical_specialty
Medicine (General)
Luminal B Breast Cancer
business.industry
Ubiquitin-Protein Ligases
Medicine (miscellaneous)
Breast Neoplasms
Letter to Editor
Risk Assessment
Risk groups
R5-920
Internal medicine
Biomarkers, Tumor
Humans
Molecular Medicine
Medicine
Female
business
Proportional Hazards Models
Subjects
Details
- Language :
- English
- ISSN :
- 20011326
- Volume :
- 11
- Issue :
- 11
- Database :
- OpenAIRE
- Journal :
- Clinical and Translational Medicine
- Accession number :
- edsair.doi.dedup.....128948af988bf46fc6814adce62dc289